An amine-derivatized DOTA has been used to modify the surface of a polymeric support for conventional Solid Phase Peptide Synthesis (SPPS) following standard Fmoc chemistry methods. This methodology was used to synthesize a peptide-DOTA conjugate that was demonstrated to be a PARACEST MRI contrast agent. Therefore, this synthesis methodology can facilitate Fmoc SPPS of molecular imaging contrast agents.
Keywords
DOTA; SPPS; Fmoc; PARACEST; MRI; Molecular ImagingMolecular imaging has recently emerged as a powerful method to provide medical information at the molecular level.1 Molecular imaging contrast agents have been conjugated to many types of peptides that target cell receptors and enzymes, in order to diagnose pathological tissues and assess early therapeutic responses.2 -5 Macrocyclic metal chelates, such as metallated 1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetic acid (DOTA) have been conjugated to peptides and detected with MRI, PET and SPECT imaging.6 -8 As a testament to their potential, 23% (187 of 820) of the journal publications that describe molecular imaging contrast agents with metal chelates contain one or more peptidyl ligands. As a testament to their demonstrated utility for biomedical imaging, 8% (46 of 594) of the entries in the Molecular Imaging Contrast Agent Database (MICAD) consist of metal chelates with one or more peptidyl ligands.9The facile synthesis of metal chelate contrast agents that include peptides is needed to accelerate the research and clinical translation of molecular imaging. Previously reported methods have conjugated the carboxylates of DOTA to the amines of peptides, including the N-terminus, the side chain of lysine, and unnatural amino acid derivatives. 10 DOTA derivatives of succinimide and isothiocyanate have also been conjugated to peptide amino groups. 11,12 However, coupling DOTA only to peptide amines can limit synthesis methodologies. 13,14 * To whom correspondence should be addressed. Mark D. Pagel, Associate Professor, The University of Arizona, Arizona Cancer Center, #4949B, 1515 N. Campbell Avenue, Tucson, AZ 85724-5024, Phone : (520) 404-7049, Fax : (520) 626-0395, E-Mail: mpagel@u.arizona.edu. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
NIH-PA Author ManuscriptNIH-PA Author Manuscript
NIH-PA Author ManuscriptTo resolve these limitations in the synthesis of peptidyl DOTA conjugates, we previously developed an amine-derivatized DOTA and used this product to couple DOTA to the Cterminus of a peptide using soution-phase methods. 15 We have also loaded an aminederivatized DOTA onto ...